Lenvatinib mesylate
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities.
Product Specifications
CAS Number
857890-39-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
522.96
Molecular Formula
C₂₂H₂₃ClN₄O₇S
Notes
Research use only, not for human use.
Receptor
——
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![LIPG Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1D9]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
TA501016AM 100 µL
LIPG Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1D9]
Sign In for Pricing
View Details 128682-ML405 100 µL
JMJD1C (Probable JmjC Domain-containing Histone Demethylation Protein 2C, Jumonji Domain-containing Protein 1C, Thyroid Receptor-interacting Protein 8, TR-interacting Protein 8, TRIP-8, JHDM2C, KIAA1380, TRIP8, DKFZp761F0118, FLJ14374, RP11-10C13.2) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
MBS6188642-01 0.1 mL
TGFB2 (TGFB2, Transforming growth factor beta-2, BSC-1 cell growth inhibitor, Cetermin, Glioblastoma-derived T-cell suppressor factor, Polyergin) (MaxLight 405)
Sign In for Pricing
View Details MBS6188642-02 5x 0.1 mL
TGFB2 (TGFB2, Transforming growth factor beta-2, BSC-1 cell growth inhibitor, Cetermin, Glioblastoma-derived T-cell suppressor factor, Polyergin) (MaxLight 405)
Sign In for Pricing
View Details